European Academy of Optometry and Optics

Only around 36% of the estimated 1.25 billion people who need corrective treatment for distance vision impairments have access to a suitable solution.[1]  This immense vision health gap is still growing, signifying the demand for innovation in vision care. For over 60 years, HOYA Vision Care believes that everyone deserves better care and treatment for their eye health. Therefore, as a global leader in the spectacle lens industry, HOYA Vision Care is dedicated to providing innovative vision care solutions for every stage of a patient’s life.
Report of the 2030 targets on effective coverage of eye care. 12 October 2022.

By collaborating with and supporting Eye Care Professionals (ECPs) globally, HOYA strives to remain the trusted partner for ECPs and ensures that real clinical needs are at the heart of their innovations. In furthering this commitment, HOYA Vision Care is very proud to have been associated with the European Academy of Optometry and Optics (EAOO) for over a decade. This year, HOYA is proud to support the 16th Annual EAOO conference in Ljubljana, Slovenia, as a Platinum Sponsor.

Explore clinical evidence-backed insights transforming the future of eye health

Exploring new frontiers in technological innovation and supporting these innovations with evidence is what drives the offerings at HOYA Vision Care. At EAOO 2025 and throughout the year’s congress activities, HOYA shares its latest clinical evidence and experience as part of their commitment to delivering clinical evidence across the full spectrum of vision care expertise.

HOYA Vision Care now has over 8 years[2] of clinical evidence demonstrating the effectiveness and safety of MiYOSMART spectacle lenses, representing the longest follow-up clinical study for myopia management spectacle lenses. Further, at the EAOO Meeting 2025 plenary sessions, HOYA will present findings from other clinical studies such as their  2-year European Observational clinical study evaluating MiYOSMART spectacle lens effectiveness in European children, and evidence on combination treatment for myopia management. Join the below sessions to deep-dive into their latest findings and more. Click on the link for complete session details:

Review of the role of accommodation and binocular vision in myopia onset and progression

Presented by Professor Bruce Evans

Date: May 17th, 2025 | Time: 09:00 – 09:30 |Location: Linhart Hall

Student Researcher And Early Career Researcher Session

Influence of different types of astigmatism on myopia progression in children wearing defocus incorporated multiple segments spectacles, presented by Jenna Hoogendoorn

Date: May 17th, 2025 | Time: 9:00 – 10:30 | Location: Kosovel Hall

Exploring New Frontiers in Myopia Management with MiYOSMART

Myopia Management in Anisometropic Children by Professor Bruce Evans

The MiYOSMART Evidence Quiz by Marianne Goldwaser & Pascal Blaser

Date: May 17th, 2025 |Time: 17:00 – 17:30 | Location: Kosovel Hall

Rapid Fire Session VI: Binocular Vision

Prevalence of amblyogenic risk factors among children aged 3.5-5.5 years in Scotland who fail their vision screening: a retrospective epidemiological study presented by Dr. Miriam Conway

Date: May 18th, 2025 | Time: 10:30 – 11:00 | Location: Kosovel Hall

Rapid Fire Session VII: Myopia

1. Vision related quality of life of myopic children using combination treatment: Atropine and defocus incorporated multiple segments spectacle lens. by Paloma Porras Ángel
2. Atropine and spectacle lens combination treatment (ASPECT): 12-month results of a randomized controlled trial for myopia control by Rafael Bella-Gala
3. Eight years of performance of defocus incorporated multiple segments (DIMS) spectacle lenses: User experience and myopia management outcomes. by Dr. Natalia Vlasak
4. Multi-site observational study of defocus incorporated multiple segments (DIMS) spectacle lenses in UK children: 2-year results. by Professor Kathryn Saunders

Date: May 18th, 2025 |Time: 11:30 – 12:30 | Location: Kosovel Hall

Commitment towards enabling patients to lead fuller lives

HOYA Vision Care is committed to fighting refractive error through advanced, evidence-based solutions that allow people of all ages to lead fuller lives. Early signs of presbyopia often appear in the mid-30s, and addressing them promptly is vital for maintaining quality of life and clear vision.  To learn more about HOYA’s approach to combatting refractive error, and spotting the first signs of Pre-Presbyopia, join their workshop on:

Pre-Presbyopia – A New Category in Vision Care and Identifying the Need for Early Solutions

Conducted by Maarten Brouwer, Global Global Training and Education Manager, HOYA Vision Care.

Date: 16^th May 2025 | Time: 09:00 to 10.30 | Location: Room E1

Experience the latest innovations at the HOYA Vision Care Booth

Spectacle lens centration is essential for new spectacles and needs to be completed precisely and reliably. HOYA Vision Care’s AI-powered visuReal Master^AI system ensures a fast, precise, and easy centration process, crucial for personalized spectacle lenses. HOYA is excited to announce an efficient and easy module to their portable video centration system visuReal Move^AI. Discover HOYA’s video centration module, launching live at EAOO 2025.

Experience and learn more about their latest VisuPro spectacle lenses, HOYA’s latest offering in pre-presbyopic care. These lenses are made by incorporating proprietary technologies shaped by patient insights.

Don’t miss the newly launched MiYOSMART spectacle lenses with an extended power range up to -13.00D. This innovation ensures that even children with high myopia can benefit, because every diopter counts.

HOYA Vision Care believes that by fostering collaboration between industry experts and forums such as EAOO, ECPs, and the greater eye care ecosystem, together we can empower individuals to take proactive steps to protect their vision.

To register for the conference, please visit: Register – EAOO 2025

Disclaimers:

*MiYOSMART spectacle lenses have not been approved for myopia management in all countries, including the United States, and are not currently available for sale in all countries.

HOYA, the HOYA Vison Care logo, MiYOSMART, the VISUPRO logo, and Binocular Harmonization Technology are registered trademarks of HOYA Corp.

[1] World Health Organization. Report of the 2030 targets on effective coverage of eye care. 12 October 2022. Available at: https://www.who.int/publications/i/item/9789240058002. Accessed: April 2025.

[2]  Lam CSY, et al. Eight Years of Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses: User Experience and Myopia Control Outcomes. Abstract presented at The International Myopia Conference (IMC) 2024, Hainan, China.